FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > FSD Pharma updates recent

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Feb 03, 2023 10:57am

76 Views

Post# 35264791

RE:RE:RE:FSD Pharma updates recent

Talk is cheap Rosenberg...but the financials speak for themselves.....take a look at the last financial statement dated Nov 11, 2022.....

9 months ending 30 Sep 22
Salaries, benefits, bonuses and consulting fees                   1,390,070
Share-based payments and bonuses                                      828,664
                                                                                              2,218,734

Total operating expenses                                                     20,769,836

How much cash on hand Rosenberg....$40M or so.....no cash coming in....unsustainable expenses.....so you tell us how they'll have enough funds to finish a trial that will take years if not a decade?

DavidRosenberg wrote:

Mil_Man54 wrote: And they don't have enough money to complete even one trial!

talk is cheap , show proof to me that they don't have enough money to start trials

their financials showed they have money to start all 3 trials

they also sold the cannabis facility for gains so your comments are misleading milman not mine

https://www.businesswire.com/news/home/20220510005660/en/FSD-Pharma-Closes-CAD16.4-Million-Sale-of-Non-Core-Assets